When a wellness product promises to "boost immunity," "support joint health," or "reduce the risk of disease," two U.S. federal agencies may be watching — and they divide the work differently than most consumers expect. The Food and Drug Administration (FDA) primarily governs claims on product labeling, while the Federal Trade Commission (FTC) polices the truthfulness of claims in advertising across every channel. The same sentence can clear the label review and still fail as an ad, because each agency applies a different legal framework to the same product. Exponent, a consulting firm that evaluates consumer health claims, identifies this as the defining structural feature of the landscape: the two agencies' authorities overlap on health product marketing, but neither is interchangeable with the other.

Understanding that split — along with the "competent and reliable scientific evidence" standard that advertising claims must meet — gives readers a workable framework for judging whether a health claim deserves their trust. It also explains a recurring frustration for consumers: why a claim that appears permissible in one context, such as a brand's website, may be problematic in another, such as on the package itself.

Navigating the Regulatory Landscape for Health Claims

The regulatory picture for health and wellness products is complicated by a simple fact: a product's regulatory status can change depending on the claim being made. A wellness device that merely "promotes relaxation" may fall outside device regulation entirely, while a nearly identical product claiming to treat anxiety may be regulated as a medical device. Exponent's analysis of consumer health claims emphasizes this claim-driven shift as a defining feature of the market.

The FDA's Center for Devices and Radiological Health has issued guidance clarifying its compliance policy for low-risk products that promote a healthy lifestyle — so-called general wellness products. Under section 520(o)(1)(B) of the Federal Food, Drug, and Cosmetic (FD&C) Act, software intended "for maintaining or encouraging a healthy lifestyle and is unrelated to the diagnosis, cure, mitigation, prevention, or treatment of a disease or condition" is not a device. FDA's guidance interprets that provision for general wellness products, and the agency notes the guidance does not change or rescind any requirements of the FD&C Act or applicable regulations.

That statutory boundary — wellness on one side, disease on the other — runs through nearly every claim category in this market. It is also narrower than many brands assume: the FDA's device-center guidance does not apply to products such as drugs, biologics, dietary supplements, foods, or cosmetics, which are regulated by other FDA centers. A claim's category and the product class it sits in together determine which rules actually attach.